Research programme: antibacterials - Protein Design LabsAlternative Names: Antibacterials research programme - Protein Design Labs
Latest Information Update: 04 Oct 2001
At a glance
- Originator PDL BioPharma
- Class Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 04 Oct 2001 Discontinued-Preclinical for Bacterial infections in USA (Unknown route)
- 22 Sep 1999 New profile
- 22 Sep 1999 Preclinical development for Bacterial infections in USA (Unknown route)